Daniel Schöndube

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 62 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Chemomodulation of sequential high-dose cytarabine by fludarabine in relapsed or refractory acute myeloid leukemia: a randomized trial of the AMLCG

Michael Fiegl, Michael Unterhalt, Wolfgang Kern et al. · Leukemia · 2013 · 34 citations

Medicine, Oncology, Pharmacotherapy +16

Impact of Age and Midostaurin-Dose on Response and Outcome in Acute Myeloid Leukemia with FLT3-ITD: Interim-Analyses of the AMLSG 16-10 Trial

Richard F. Schlenk, Walter Fiedler, Helmut R. Salih et al. · Blood · 2016 · 22 citations

Medicine, Hematology, Oncology +8

Mortality in cancer patients with SARS-CoV-2 or seasonal influenza: an observational cohort study from a German-wide hospital network

Cathrin Kodde, Marzia Bonsignore, Daniel Schöndube et al. · Infection · 2022 · 11 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin’s lymphoma: results from the randomized international GHSG HD18 trial

Justin Ferdinandus, Horst Müller, Carla Damaschin et al. · Annals of Oncology · 2023 · 10 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +16